Search
for
Sort by
Research 121–150 of 748
- [What is the value of low-energie lasers in the treatment of androgenetic alopecia ?]
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- 13. Wound Healing & Hair
- Role of ACE2 polymorphism in COVID-19: impact of age
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Human genetic basis of coronavirus disease 2019
- Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population
- OR2AT4, an Ectopic Olfactory Receptor, Suppresses Oxidative Stress-Induced Senescence in Human Keratinocytes
- Techniques d'épargne cutanée dans la chirurgie de la gynécomastie
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Norgalanthamine Stimulates Proliferation of Dermal Papilla Cells <i>via</i> Anagen-Activating Signaling Pathways
- Malignant epithelial tumors: Part II. Therapy and prevention
- Discovering the potential of natural remedies in the post COVID-19 complications based on in silico techniques
- Research on the Mechanism of Hair Dyeing Agents and Strategies for Health Risks Reduction
- Scalp acupoint catgut embedding combined with topical 5% minoxidil tincture to improve male androgenetic alopecia: protocol for a randomised controlled trial
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- ENZYMES
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Severe Acute Respiratory Syndrome (SARS)
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- Alleviation of Mechanical Allodynia by 14,15-Epoxyeicosatrienoic Acid in a Central Poststroke Pain Model: Possible Role of Allopregnanolone and δ-Subunit-Containing Gamma-Aminobutyric Acid A Receptors
- The correlation between corona virus disease 2019 and alopecia areata: a literature review